文献速递角膜与眼表疾病青光眼

Ripasudil滴眼液后角膜内皮细胞形态变化与恢复

Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation.
PubMed 文献 · Br J Ophthalmol · 2020-04-08

这项观察性研究纳入163例青光眼患者163眼,评估Ripasudil 0.4%滴眼后角膜内皮细胞形态和密度变化。结果显示点药后1小时内出现形态改变,6小时内恢复;早期组和中期组角膜内皮细胞密度变化率中位数分别为-5.68%和-4.95%,晚期组为-0.07%。

要点

  • Ripasudil点眼后1小时内角膜内皮细胞出现形态改变,6小时内恢复。
  • 点药后早期和中期用非接触镜面显微镜自动软件测得的角膜内皮细胞密度偏低。
  • 临床应在点药6小时后测量角膜内皮细胞密度以避免误判。

核心结论

  • Ripasudil 0.4%滴眼后1小时内角膜内皮细胞形态改变导致自动软件测得的密度数据不可靠,但形态在6小时内逐渐恢复正常。

研究设计与样本

  • 观察性研究,纳入163例青光眼患者163眼,按点药后时间分为早期组(<2小时)、中期组(≥2小时且<6小时)和晚期组(≥6小时)。
  • 另纳入4例患者8眼进行时间依赖性研究,在点药前及点药后1、2、3、4、6小时进行非接触镜面显微镜检查。

主要发现

  • 角膜内皮细胞形态改变在点药后1小时内出现,6小时内恢复正常。
  • 早期组、中期组和晚期组角膜内皮细胞密度变化率中位数分别为-5.68%、-4.95%和-0.07%。
  • 时间依赖性研究中4例患者的角膜内皮细胞图像显示与观察性研究相同的形态变化。

临床怎么用

  • 使用Ripasudil的患者如需评估角膜内皮细胞密度,应避免在点药后6小时内进行非接触镜面显微镜检查。
  • 若在点药后早期检查发现角膜内皮细胞密度下降,应考虑为一过性形态改变所致,而非真实密度减少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: To investigate the time-dependent change of corneal endothelial cell (CEC) morphology and density (CECD) in patients with glaucoma post instillation of rho-associated protein kinase inhibitor ripasudil (Rip) 0.4% eye drops. METHODS: This observational study involved 163 eyes of 163 patients with glaucoma in whom CEC morphological change was evaluated by CECD calculated via non-contact specular microscopy (NCSM) before and at 1 or 3 months post-Rip instillation. The change of CECD was plotted along with elapsed time from last instillation of Rip. The patients were divided into the following three groups based on the elapsed time post-Rip instillation: Early Group (<2 hours), Middle Group (≥2 hours, yet <6 hours) and Late Group (≥6 hours). The rate of CECD change was then analysed and compared among the three groups. An additional eight eyes of four patients with glaucoma were enrolled for a time-dependent study, with NCSM images evaluated before and at 1, 2, 3, 4 and 6 hours post-Rip instillation. RESULTS: Morphological changes in the CECs appeared within 1 hour and recovered to normal within 6 hours post instillation. In the Early, Middle and Late Group, the median rate of CECD change as calculated by the NCSM automated software was -5.68%, -4.95% and -0.07%, respectively. The CEC images showed the same morphological changes with observational study in all four cases. CONCLUSION: Due to transient morphological changes, the NCSM software produced misleading data for determining CECD within 1 hour post-Rip instillation, yet revealed that CEC morphology gradually recovered to normal within 6 hours.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Maruyama Y, Ikeda Y, Mori K, et al. Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation. Br J Ophthalmol. 2020. PMID: 32269062. doi:10.1136/bjophthalmol-2019-315776

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。